Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer

Abstract

FDG-PET can aid in monitoring the clinical outcome of patients with locally advanced pancreatic cancer treated with neoadjuvant chemo-RT. FDG-PET may be used to aid patients who could have complete surgical resection as well as prognosticate patients' survival.

References

Page 1

	Year	Citations
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing Yoav Benjamini, Yosef Hochberg Journal of the Royal Statistical Society Series B (Statistical Methodology) EngineeringStatistical FoundationPowerful ApproachDiagnosisData Mining	1995	105.5K
Cancer Statistics, 2008 Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward, CA A Cancer Journal for Clinicians Cancer StatisticsEpidemiologyCancer EpidemiologyMedicineEpidemiology Of Cancer	2008	10.2K
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data Clifford S. Patlak, Ronald G. Blasberg, Joseph D. Fenstermacher Journal of Cerebral Blood Flow & Metabolism EngineeringNeurophysiological BiomarkersBiomedical EngineeringCerebral Vascular RegulationBlood Flow	1983	3.6K
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome Corinne Haïoun, Emmanuel Itti, Alain Rahmouni, Blood	2005	496
Reproducibility of metabolic measurements in malignant tumors using FDG PET. Wolfgang Weber, Sibylle Ziegler, R. Thödtmann, PubMed	1999	394
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma Martin Hutchings, N. George Mikhaeel, Paul Fields, Annals of Oncology Lymphoid NeoplasiaHodgkin LymphomaMedicinePrognostic ValueCancer Treatment	2005	326
Carcinoma of the Pancreatic Head and Periampullary Region Tumor Staging with Laparoscopy and Laparoscopic Ultrasonography Timothy G. John, J. Donald Greig, David C. Carter, Annals of Surgery	1995	320
2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma Stephen G. Swisher, Jeremy Erasmus, Mary S. Maish, Cancer	2004	265
Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Heikki Minn, Kenneth Zasadny, L E Quint, Radiology	1995	263
Prognostic Relevance of Response Evaluation Using [<sup>18</sup>F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer C. Hoekstra, Sigrid Stroobants, Egbert F. Smit, Journal of Clinical Oncology	2005	248

Page 1